Yang Yu

Dr. Yang Yu

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2025 in Nature Materials
Verified
Journal Article
Closed access
PDF file
CWChang Wang
Chang Wang
YXYonger Xue
Yonger Xue
TMTamara Markovic
Tamara Markovic
HLHaoyuan Li
Haoyuan Li
SWSiyu Wang
Siyu Wang
YDYizhou Dong
Yizhou Dong

20 January 2023 in Circulation Research
Verified
Journal Article
Open access
PDF file
SYShiqiao Ye
Shiqiao Ye
CWCankun Wang
Cankun Wang
ZXZhaohui Xu
Zhaohui Xu
HLHui Lin
Hui Lin
XWXiaoping Wan
Xiaoping Wan
Mingtao ZhaoMingtao Zhao
Mingtao Zhao
Background: NOTCH1 pathogenic variants are implicated in multiple types of congenital heart defects including hypoplastic left heart syndrome, where the left ventricle is underdeveloped. It is unknown how NOTCH1 regulates human cardiac cell lineage determination and cardiomyocyte proliferation. In addition, mechanisms by which NOTCH1 pathogenic variants lead to ventricular hypoplasia in hypoplastic left heart syndrome remain elusive. Methods: CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 genome editing was utilized to delete NOTCH1 in human induced pluripotent stem cells. Cardiac differentiation was carried out by sequential modulation of WNT signaling, and NOTCH1 knockout and wild-type differentiating cells were collected at day 0, 2, 5, 10, 14, and 30 for single-cell RNA-seq. Results: Human NOTCH1 knockout induced pluripotent stem cells are able to generate functional cardiomyocytes and endothelial cells, suggesting that NOTCH1 is not required for mesoderm differentiation and cardiovascular development in vitro. However, disruption of NOTCH1 blocks human ventricular-like cardiomyocyte differentiation but promotes atrial-like cardiomyocyte generation through shortening the action potential duration. NOTCH1 deficiency leads to defective proliferation of early human cardiomyocytes, and transcriptomic analysis indicates that pathways involved in cell cycle progression and mitosis are downregulated in NOTCH1 knockout cardiomyocytes. Single-cell transcriptomic analysis reveals abnormal cell lineage determination of cardiac mesoderm, which is manifested by the biased differentiation toward epicardial and second heart field progenitors at the expense of first heart field progenitors in NOTCH1 knockout cell populations. Conclusions: NOTCH1 is essential for human ventricular-like cardiomyocyte differentiation and proliferation through balancing cell fate determination of cardiac mesoderm and modulating cell cycle progression. Because first heart field progenitors primarily contribute to the left ventricle, we speculate that pathogenic NOTCH1 variants lead to biased differentiation of first heart field progenitors, blocked ventricular-like cardiomyocyte differentiation, and defective cardiomyocyte proliferation, which collaboratively contribute to left ventricular hypoplasia in hypoplastic left heart syndrome.

25 November 2024 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
CWChang Wang
Chang Wang
SWSiyu Wang
Siyu Wang
YXYonger Xue
Yonger Xue
YZYichen Zhong
Yichen Zhong
HLHaoyuan Li
Haoyuan Li
YDYizhou Dong
Yizhou Dong

4 January 2023 in Expert Reviews in Molecular Medicine
Verified
Journal Article
Open access
PDF file
YYYang Yu
Yang Yu
IDIsabelle Deschenes
Isabelle Deschenes
Mingtao ZhaoMingtao Zhao
Mingtao Zhao
Long QT syndrome (LQTS) is a detrimental arrhythmia syndrome mainly caused by dysregulated expression or aberrant function of ion channels. The major clinical symptoms of ventricular arrhythmia, palpitations and syncope vary among LQTS subtypes. Susceptibility to malignant arrhythmia is a result of delayed repolarisation of the cardiomyocyte action potential (AP). There are 17 distinct subtypes of LQTS linked to 15 autosomal dominant genes with monogenic mutations. However, due to the presence of modifier genes, the identical mutation may result in completely different clinical manifestations in different carriers. In this review, we describe the roles of various ion channels in orchestrating APs and discuss molecular aetiologies of various types of LQTS. We highlight the usage of patient-specific induced pluripotent stem cell (iPSC) models in characterising fundamental mechanisms associated with LQTS. To mitigate the outcomes of LQTS, treatment strategies are initially focused on small molecules targeting ion channel activities. Next-generation treatments will reap the benefits from development of LQTS patient-specific iPSC platform, which is bolstered by the state-of-the-art technologies including whole-genome sequencing, CRISPR genome editing and machine learning. Deep phenotyping and high-throughput drug testing using LQTS patient-specific cardiomyocytes herald the upcoming precision medicine in LQTS.

12 March 2024 in Circulation
Verified
Journal Article
Closed access
YYYang Yu
Yang Yu
CWCankun Wang
Cankun Wang
SYShiqiao Ye
Shiqiao Ye
ZXZhaohui Xu
Zhaohui Xu
HLHui Lin
Hui Lin
Mingtao ZhaoMingtao Zhao
Mingtao Zhao

5 August 2016 in Medical and Veterinary Entomology
Verified
Journal Article
Closed access
PDF file
CHC. N. Hodson
C. N. Hodson
YYYang Yu
Yang Yu
EPErika Plettner
Erika Plettner
Bernard RoitbergBernard Roitberg
Bernard Roitberg